Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation

The Biochemical Journal
Anne-M KrogsdamK Kristiansen

Abstract

The nuclear receptor corepressor (NCoR) was isolated as a peroxisome-proliferator-activated receptor (PPAR) delta interacting protein using the yeast two-hybrid system. NCoR interacted strongly with the ligand-binding domain of PPAR delta, whereas interactions with the ligand-binding domains of PPAR gamma and PPAR alpha were significantly weaker. PPAR-NCoR interactions were antagonized by ligands in the two-hybrid system, but were ligand-insensitive in in vitro pull-down assays. Interaction between PPAR delta and NCoR was unaffected by coexpression of retinoid X receptor (RXR) alpha. The PPAR delta-RXR alpha heterodimer bound to an acyl-CoA oxidase (ACO)-type peroxisome-proliferator response element recruited a glutathione S-transferase-NCoR fusion protein in a ligand-independent manner. Contrasting with most other nuclear receptors, PPAR delta was found to interact equally well with interaction domains I and II of NCoR. In transient transfection experiments, NCoR and the related silencing mediator for retinoid and thyroid hormone receptor (SMRT) were shown to exert a marked dose-dependent repression of ligand-induced PPAR delta-mediated transactivation; in addition, transactivation induced by the cAMP-elevating agent forskolin...Continue Reading

References

Mar 1, 1992·Genes & Development·D J MangelsdorfR M Evans
Aug 30, 1991·Biochemical and Biophysical Research Communications·X Gao, L Huang
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·S A KliewerR M Evans
May 11, 1994·Nucleic Acids Research·C BendixenR Rothstein
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J HenzelC Watanabe
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Dec 26, 1995·Biochemical and Biophysical Research Communications·G XingS Detera-Wadleigh
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·R M LavinskyD W Rose
Nov 13, 1998·The Journal of Biological Chemistry·J UppenbergA Berkenstam
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·E J ParkJ D Chen
May 14, 1999·Current Opinion in Genetics & Development·L XuM G Rosenfeld
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·J L OberfieldT M Willson
Sep 3, 1999·Nature Biotechnology·E NordhoffK Kristiansen
Jan 5, 2000·Genes & Development·V PerissiM G Rosenfeld
Jan 5, 2000·Genes & Development·L NagyJ W Schwabe
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·R A GuptaR N DuBois
Mar 10, 2001·Recent Progress in Hormone Research·S A KliewerT M Willson
Mar 10, 2001·Molecular and Cellular Biology·X HuM A Lazar
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·W R OliverT M Willson
May 12, 2001·The Journal of Investigative Dermatology·I M FreedbergM Blumenberg
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·H E XuT M Willson

❮ Previous
Next ❯

Citations

Apr 18, 2008·Current Atherosclerosis Reports·Melanie S SulistioRobert Chilton
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Christophe BlanquartCorine Glineur
Sep 18, 2010·Nucleic Acids Research·Josefine StockertRolf Müller
Jun 28, 2008·PPAR Research·Keisuke TachibanaTakefumi Doi
Aug 2, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Keisuke Tachibana
Sep 17, 2009·PloS One·Mattias C U GustafssonColin N A Palmer
Dec 24, 2013·Progress in Lipid Research·Manabu T NakamuraJuan J Loor
Jul 2, 2014·Journal of Molecular Endocrinology·Xiaoting JiangZhanguo Gao
Jun 26, 2012·Trends in Pharmacological Sciences·Zvonimir S KatusicTongrong He
Jul 15, 2011·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Michele VaccaAntonio Moschetta
Dec 22, 2004·The Journal of Investigative Dermatology·Anthony M FloresBrian J Aneskievich
Dec 1, 2005·Expert Opinion on Pharmacotherapy·Sharon Cresci
Aug 2, 2007·Expert Opinion on Therapeutic Targets·Efstathia PapageorgiouMichael Koutsilieris
Aug 9, 2005·Expert Opinion on Therapeutic Targets·Elodie BeduBéatrice Desvergne
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·Florian BlaschkeWilla A Hsueh
Apr 30, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Nguan Soon TanWalter Wahli
Oct 19, 2004·Journal of Lipid Research·Andrew C Li, Christopher K Glass
Jan 1, 2015·Journal of Experimental Neuroscience·Ana Maria OlivaresNeena B Haider
Oct 26, 2006·The Journal of Biological Chemistry·Tatjana DegenhardtCarsten Carlberg
Feb 19, 2008·The Journal of Biological Chemistry·Teresa CollManuel Vázquez-Carrera
Nov 30, 2006·Pharmacological Reviews·Liliane MichalikWalter Wahli
Nov 21, 2002·The Journal of Biological Chemistry·Guoqing LiaoJ Don Chen
May 13, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zhanfang Kang, Rongrong Fan
Jun 3, 2006·Vascular Pharmacology·Florian BlaschkeRonald E Law
Jun 30, 2006·Molecular and Cellular Endocrinology·Kimihiko MatsusueFrank J Gonzalez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.